Posted by: admin on: September 21, 2011
Although the updated heart failure guidelines from the U.K.’s National Institute for Health and Clinical Excellence (NICE) are broadly consistent with similar guidelines from Europe and the U.S., outside experts are questioning several key details of the update. -Team@CMHF
Posted by: admin on: September 19, 2011
In new guidelines from the European Society of Cardiology (ESC), Prasugrel – a once daily oral antiplatelet medicine – received a Class I recommendation for use in patients undergoing percutaneous coronary intervention (PCI) after experiencing a non-ST-segment elevation acute coronary syndrome (which comprises non-ST segment elevation myocardial infarction or NSTEMI – a type of heart […]
Posted by: admin on: September 16, 2011
Two CPR strategies intended to improve patient survival after out-of-hospital cardiac arrest were found to have no significant effect in two related randomized clinical trials published in the Sept. 1 issue of the New England Journal of Medicine -Team@CMHF
Posted by: admin on: September 12, 2011
Therapies, such as the use of fibrinolytic drugs, catheter-based interventions, surgery or use of vena cava filters, should be considered in addition to blood thinners when treating certain patients with deep vein thrombosis and pulmonary embolism, according to a scientific statement published a few months back. Team@CMHF
Posted by: admin on: September 8, 2011
Here is a study on treatment with statins monotherapy and statins in combination therapy for dyslipidemia. Combination therapy has been found to be more useful Team@CMHF